On October 16, 2009
Winners and Losers in Senate Bill on Pay-for-Delay Deals
The Senate Judiciary Committee passed a bill that would bar drug companies from paying to prevent generic rivals to their branded drugs from being launched. So called “pay-for-delay” deals prevent cheap generics from reaching the market for years, the bill’s proponents argue. By banning the deals, consumers will benefit from generics arriving sooner. So who wins and who loses if the bill is passed?
0 Comments